tradingkey.logo
tradingkey.logo
Search

Becton Dickinson and Co

BDX
Add to Watchlist
140.710USD
0.0000.00%
Close 06/22, 16:00ETQuotes delayed by 15 min
38.77BMarket Cap
35.45P/E TTM

TradingKey Stock Score of Becton Dickinson and Co

Currency: USD Updated: 2026-06-22

Key Insights

Becton Dickinson and Co's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 63 out of 203 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 183.44.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Becton Dickinson and Co's Score

Industry at a Glance

Industry Ranking
63 / 203
Overall Ranking
177 / 4577
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative-

Becton Dickinson and Co Highlights

StrengthsRisks
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 21.84B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 71.28%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 71.28%.
Fairly Valued
The company’s latest PE is 35.45, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 241.06M shares, decreasing 16.25% quarter-over-quarter.
Held by First Pacific Advisors
Star Investor First Pacific Advisors holds 2.11M shares of this stock.

Analyst Rating

Based on 17 analysts
Buy
Current Rating
183.436
Target Price
+27.40%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

How does TradingKey generate the Stock Score of Becton Dickinson and Co?

The TradingKey Stock Score provides a comprehensive assessment of Becton Dickinson and Co based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Becton Dickinson and Co’s performance and outlook.

How do we generate the financial health score of Becton Dickinson and Co?

To generate the financial health score of Becton Dickinson and Co, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Becton Dickinson and Co's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Becton Dickinson and Co.

How do we generate the company valuation score of Becton Dickinson and Co?

To generate the company valuation score of Becton Dickinson and Co, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Becton Dickinson and Co’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Becton Dickinson and Co’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Becton Dickinson and Co.

How do we generate the earnings forecast score of Becton Dickinson and Co?

To calculate the earnings forecast score of Becton Dickinson and Co, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Becton Dickinson and Co’s future.

How do we generate the price momentum score of Becton Dickinson and Co?

When generating the price momentum score for Becton Dickinson and Co, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Becton Dickinson and Co’s prices. A higher score indicates a more stable short-term price trend for Becton Dickinson and Co.

How do we generate the institutional confidence score of Becton Dickinson and Co?

To generate the institutional confidence score of Becton Dickinson and Co, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Becton Dickinson and Co’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Becton Dickinson and Co.

How do we generate the risk management score of Becton Dickinson and Co?

To assess the risk management score of Becton Dickinson and Co, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Becton Dickinson and Co’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Becton Dickinson and Co.
KeyAI